Matches in SemOpenAlex for { <https://semopenalex.org/work/W4315785087> ?p ?o ?g. }
- W4315785087 endingPage "e003075" @default.
- W4315785087 startingPage "e003075" @default.
- W4315785087 abstract "Introduction Type 2 diabetes mellitus (T2DM) has traditionally been considered a coronary heart disease ‘risk equivalent’ for future mortality, but significant heterogeneity exists across people with T2DM. This study aims to determine the risk of all-cause mortality of patients with cardiovascular disease (CVD) and T2DM in UK and Hong Kong, with stratifications for hemoglobin A1 (HbA1c) concentrations, compared with those without CVD and diabetes mellitus. Research design and methods This is a retrospective cohort study of 3 839 391 adults from Hong Kong and a prospective cohort study of 497 779 adults from the UK Biobank. Individuals were divided into seven disease groups: (1) no T2DM and CVD, (2) T2DM only with HbA1c <7%, (3) T2DM only with HbA1c 7%–7.9%, (4) T2DM only with HbA1c 8%–8.9%, (5) T2DM only with HbA1c ≥9%, (6) CVD only, and (7) T2DM and CVD. Differences in all-cause mortality between groups were examined using Cox regression. Results After around 10 years of median follow-up, 423 818 and 19 844 deaths were identified in the Hong Kong cohort and UK Biobank, respectively. Compared with individuals without T2DM and CVD, the adjusted HR for all-cause mortality in the other six disease groups for the Hong Kong cohort was 1.25 (95% CI 1.23 to 1.27) for T2DM only with HbA1c <7%, 1.21 (95% CI 1.19 to 1.23) for T2DM only with HbA1c 7%–7.9%, 1.36 (95% CI 1.33 to 1.39) for T2DM only with HbA1c 8%–8.9%, 1.82 (95% CI 1.78 to 1.85) for T2DM only with HbA1c ≥9%, 1.37 (95% CI 1.36 to 1.38) for CVD only, and 1.83 (95% CI 1.81 to 1.85) for T2DM and CVD, and for the UK Biobank the HR was 1.45 (95% CI 1.33 to 1.58), 1.50 (95% CI 1.32 to 1.70), 1.72 (95% CI 1.43 to 2.08), 2.51 (95% CI 2.05 to 3.08), 1.67 (95% CI 1.59 to 1.75) and 2.62 (95% CI 2.42 to 2.83), respectively. This indicates that patients with T2DM had an increased risk of mortality compared with those without T2DM and CVD, and in those with HbA1c ≥9% an even higher risk than people with CVD. Conclusions Patients with T2DM with poor HbA1c control (8%–8.9% and ≥9%) were associated with similar and higher risk of mortality compared with patients with CVD, respectively. Optimal HbA1c, controlled for risk reduction and prevention of mortality and complications in diabetes management, remains important." @default.
- W4315785087 created "2023-01-13" @default.
- W4315785087 creator A5015626145 @default.
- W4315785087 creator A5023097657 @default.
- W4315785087 creator A5035152212 @default.
- W4315785087 creator A5037095037 @default.
- W4315785087 creator A5052760891 @default.
- W4315785087 creator A5056628827 @default.
- W4315785087 creator A5063190766 @default.
- W4315785087 creator A5082409466 @default.
- W4315785087 date "2023-01-01" @default.
- W4315785087 modified "2023-09-30" @default.
- W4315785087 title "Diabetes with poor-control HbA1c is cardiovascular disease ‘risk equivalent’ for mortality: UK Biobank and Hong Kong population-based cohort study" @default.
- W4315785087 cites W144619522 @default.
- W4315785087 cites W1985006642 @default.
- W4315785087 cites W2063489619 @default.
- W4315785087 cites W2082704080 @default.
- W4315785087 cites W2096409056 @default.
- W4315785087 cites W2100182767 @default.
- W4315785087 cites W2112706810 @default.
- W4315785087 cites W2121748096 @default.
- W4315785087 cites W2123946565 @default.
- W4315785087 cites W2137356728 @default.
- W4315785087 cites W2144773938 @default.
- W4315785087 cites W2153552938 @default.
- W4315785087 cites W2160840037 @default.
- W4315785087 cites W2165280863 @default.
- W4315785087 cites W2165872891 @default.
- W4315785087 cites W2190797165 @default.
- W4315785087 cites W2223238228 @default.
- W4315785087 cites W2234629397 @default.
- W4315785087 cites W2331274940 @default.
- W4315785087 cites W2557593366 @default.
- W4315785087 cites W2567007802 @default.
- W4315785087 cites W2773880106 @default.
- W4315785087 cites W2807965683 @default.
- W4315785087 cites W2885657542 @default.
- W4315785087 cites W2895486342 @default.
- W4315785087 cites W3038575402 @default.
- W4315785087 cites W3191438335 @default.
- W4315785087 cites W3215866497 @default.
- W4315785087 cites W4230870013 @default.
- W4315785087 cites W4238251256 @default.
- W4315785087 doi "https://doi.org/10.1136/bmjdrc-2022-003075" @default.
- W4315785087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36634978" @default.
- W4315785087 hasPublicationYear "2023" @default.
- W4315785087 type Work @default.
- W4315785087 citedByCount "0" @default.
- W4315785087 crossrefType "journal-article" @default.
- W4315785087 hasAuthorship W4315785087A5015626145 @default.
- W4315785087 hasAuthorship W4315785087A5023097657 @default.
- W4315785087 hasAuthorship W4315785087A5035152212 @default.
- W4315785087 hasAuthorship W4315785087A5037095037 @default.
- W4315785087 hasAuthorship W4315785087A5052760891 @default.
- W4315785087 hasAuthorship W4315785087A5056628827 @default.
- W4315785087 hasAuthorship W4315785087A5063190766 @default.
- W4315785087 hasAuthorship W4315785087A5082409466 @default.
- W4315785087 hasBestOaLocation W43157850871 @default.
- W4315785087 hasConcept C116567970 @default.
- W4315785087 hasConcept C126322002 @default.
- W4315785087 hasConcept C134018914 @default.
- W4315785087 hasConcept C188816634 @default.
- W4315785087 hasConcept C201903717 @default.
- W4315785087 hasConcept C2777180221 @default.
- W4315785087 hasConcept C2779134260 @default.
- W4315785087 hasConcept C2780920962 @default.
- W4315785087 hasConcept C2908647359 @default.
- W4315785087 hasConcept C2910068830 @default.
- W4315785087 hasConcept C555293320 @default.
- W4315785087 hasConcept C60644358 @default.
- W4315785087 hasConcept C71924100 @default.
- W4315785087 hasConcept C72563966 @default.
- W4315785087 hasConcept C86803240 @default.
- W4315785087 hasConcept C99454951 @default.
- W4315785087 hasConceptScore W4315785087C116567970 @default.
- W4315785087 hasConceptScore W4315785087C126322002 @default.
- W4315785087 hasConceptScore W4315785087C134018914 @default.
- W4315785087 hasConceptScore W4315785087C188816634 @default.
- W4315785087 hasConceptScore W4315785087C201903717 @default.
- W4315785087 hasConceptScore W4315785087C2777180221 @default.
- W4315785087 hasConceptScore W4315785087C2779134260 @default.
- W4315785087 hasConceptScore W4315785087C2780920962 @default.
- W4315785087 hasConceptScore W4315785087C2908647359 @default.
- W4315785087 hasConceptScore W4315785087C2910068830 @default.
- W4315785087 hasConceptScore W4315785087C555293320 @default.
- W4315785087 hasConceptScore W4315785087C60644358 @default.
- W4315785087 hasConceptScore W4315785087C71924100 @default.
- W4315785087 hasConceptScore W4315785087C72563966 @default.
- W4315785087 hasConceptScore W4315785087C86803240 @default.
- W4315785087 hasConceptScore W4315785087C99454951 @default.
- W4315785087 hasFunder F4320322170 @default.
- W4315785087 hasIssue "1" @default.
- W4315785087 hasLocation W43157850871 @default.
- W4315785087 hasLocation W43157850872 @default.
- W4315785087 hasLocation W43157850873 @default.
- W4315785087 hasLocation W43157850874 @default.
- W4315785087 hasOpenAccess W4315785087 @default.
- W4315785087 hasPrimaryLocation W43157850871 @default.